[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2019004984A3 - A pharmaceutical formulation comprising cholecalciferol - Google Patents

A pharmaceutical formulation comprising cholecalciferol Download PDF

Info

Publication number
WO2019004984A3
WO2019004984A3 PCT/TR2018/050236 TR2018050236W WO2019004984A3 WO 2019004984 A3 WO2019004984 A3 WO 2019004984A3 TR 2018050236 W TR2018050236 W TR 2018050236W WO 2019004984 A3 WO2019004984 A3 WO 2019004984A3
Authority
WO
WIPO (PCT)
Prior art keywords
cholecalciferol
pharmaceutical formulation
excipient
vitamin
source
Prior art date
Application number
PCT/TR2018/050236
Other languages
French (fr)
Other versions
WO2019004984A2 (en
Inventor
Umit Cifter
Urun Kandemirer
Original Assignee
Biofarma Ilac Sanayi Ve Ticaret A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarma Ilac Sanayi Ve Ticaret A.S. filed Critical Biofarma Ilac Sanayi Ve Ticaret A.S.
Publication of WO2019004984A2 publication Critical patent/WO2019004984A2/en
Publication of WO2019004984A3 publication Critical patent/WO2019004984A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention is related to a pharmaceutical formulation in chewable tablet form comprising an active agent cholecalciferol in the range of 600 IU to 3000 IU as a vitamin D3 source and at least one excipient in a unit tablet.
PCT/TR2018/050236 2017-05-29 2018-05-16 A pharmaceutical formulation comprising cholecalciferol WO2019004984A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201707762 2017-05-29
TR2017/07762 2017-05-29

Publications (2)

Publication Number Publication Date
WO2019004984A2 WO2019004984A2 (en) 2019-01-03
WO2019004984A3 true WO2019004984A3 (en) 2019-03-07

Family

ID=64741744

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050236 WO2019004984A2 (en) 2017-05-29 2018-05-16 A pharmaceutical formulation comprising cholecalciferol

Country Status (1)

Country Link
WO (1) WO2019004984A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900014550A1 (en) * 2019-08-09 2021-02-09 Abiogen Pharma Spa USE OF CHOLECALCIFEROL AS AN ACTIVE AGENT IN THE TREATMENT OF CELIACIA

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055500A1 (en) * 2002-01-04 2003-07-10 Italfarmaco, S.A. Pharmaceutical compositions for the treatment or prevention of osteoporosis
US20090041860A1 (en) * 2004-10-25 2009-02-12 Italfarmaco, S.A. Orally-dispersible pharmaceutical compositions
US20110130370A1 (en) * 2009-11-27 2011-06-02 Les Laboratories Servier Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055500A1 (en) * 2002-01-04 2003-07-10 Italfarmaco, S.A. Pharmaceutical compositions for the treatment or prevention of osteoporosis
US20090041860A1 (en) * 2004-10-25 2009-02-12 Italfarmaco, S.A. Orally-dispersible pharmaceutical compositions
US20110130370A1 (en) * 2009-11-27 2011-06-02 Les Laboratories Servier Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin

Also Published As

Publication number Publication date
WO2019004984A2 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
MX2021006035A (en) Stable cannabinoid formulations.
BR122021018243A8 (en) LOW PH TOPICAL COMPOSITION AND METHOD TO INCREASE THE TOPICAL APPLICATION OF A COSMETICALLY ACCEPTABLE ACTIVE INGREDIENT
EP3873442A4 (en) Administration of butyrate, bete-hydroxybutyrate, cannabidiol, and related compounds in humans
MX2016008977A (en) Stabilized pharmaceutical formulations of insulin aspart.
MX2023001963A (en) Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent.
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
EP4342461A3 (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
MX2018012618A (en) Oral pharmaceutical compositions of mesalazine.
AU2017262586A1 (en) Improved drug formulations
MX2020012989A (en) Therapeutic agent for fibrosis.
MX2016015261A (en) Allisartan isoproxil solid dispersion and pharmaceutical composition thereof.
BR112018068116A2 (en) transmucosal film for montelukast administration
BR112018011476A2 (en) vitamin formulation
PH12018500817A1 (en) Pharmaceutical composition comprising metformin and lobeglitazone
WO2019004984A3 (en) A pharmaceutical formulation comprising cholecalciferol
TR201722603A2 (en) Tablet formulations comprising metformin and sitagliptin processed with hot-melt extrusion
WO2019151964A3 (en) Orally disintegrating formulations of saxagliptin
BR112017019364A2 (en) solid dispersions
BR112015028302A2 (en) nicotine tablet formulation
BR112019017314A2 (en) pharmaceutical compositions for combination therapy
EP3435990A4 (en) Stable pharmaceutical compositions for topical administration and uses thereof
TR201714150A1 (en) A Pharmaceutical Formulation In Effervescent Tablet Form Containing Cholecalciferol.
PH12020550456A1 (en) Alcohol-resistant oral pharmaceutical compositions of lorazepam
AR100820A1 (en) FORMULATIONS OF COMPRESSED BI-LAYER OF CYCLOFOSPHAMIDE AND CAPECITABINE AND HIGHLY FRACTIONED METRONOMIC ADMINISTRATION OF THE SAME
BR112018012616A2 (en) galenic formulation comprising a topical drug

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18825276

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18825276

Country of ref document: EP

Kind code of ref document: A2